The treatment duration extends to approximately 48 weeks, which is standard for obesity registration trials
46 Finally, Klonoff et al, using the Arcadia patient registry, also found no significant increase in NAION risk in patients taking semaglutide
The discovery and preclinical development of ASG-5ME, an antibody-drug conjugate targeting SLC44A4-positive epithelial tumors including pancreatic and prostate cancer
If you would like to learn more about GLP-1 medications or want to see if you might be eligible for medication-assisted weight loss, check out Mochi Health, where board-certified obesity medicine physicians can offer expertise in this realm
233,234,235 Wild-type mice exhibited a marked reduction in FAO in liver mitochondria after 4 weeks of HFD feeding, and this effect was restored after 8 weeks, 236 suggesting a resilient mitochondrial functional change in obesity-induced metabolic disorder